全文获取类型
收费全文 | 710篇 |
免费 | 30篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 27篇 |
妇产科学 | 25篇 |
基础医学 | 41篇 |
口腔科学 | 4篇 |
临床医学 | 42篇 |
内科学 | 239篇 |
皮肤病学 | 2篇 |
神经病学 | 1篇 |
特种医学 | 6篇 |
外科学 | 181篇 |
综合类 | 10篇 |
预防医学 | 138篇 |
眼科学 | 4篇 |
药学 | 10篇 |
1篇 | |
中国医学 | 3篇 |
肿瘤学 | 5篇 |
出版年
2024年 | 1篇 |
2023年 | 60篇 |
2022年 | 60篇 |
2021年 | 115篇 |
2020年 | 58篇 |
2019年 | 40篇 |
2018年 | 22篇 |
2017年 | 31篇 |
2016年 | 38篇 |
2015年 | 19篇 |
2014年 | 56篇 |
2013年 | 40篇 |
2012年 | 18篇 |
2011年 | 10篇 |
2010年 | 28篇 |
2009年 | 35篇 |
2008年 | 14篇 |
2007年 | 10篇 |
2006年 | 8篇 |
2005年 | 9篇 |
2004年 | 3篇 |
2003年 | 3篇 |
2002年 | 7篇 |
2001年 | 3篇 |
2000年 | 2篇 |
1999年 | 4篇 |
1998年 | 8篇 |
1997年 | 5篇 |
1996年 | 5篇 |
1995年 | 8篇 |
1994年 | 5篇 |
1993年 | 1篇 |
1992年 | 1篇 |
1991年 | 3篇 |
1990年 | 1篇 |
1988年 | 1篇 |
1987年 | 4篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1979年 | 1篇 |
1977年 | 2篇 |
排序方式: 共有741条查询结果,搜索用时 15 毫秒
81.
Lovric Svjetlana; Erdbruegger Uta; Kumpers Philipp; Woywodt Alexander; Koenecke Christian; Wedemeyer Heiner; Haller Hermann; Haubitz Marion 《Nephrology, dialysis, transplantation》2009,24(1):179-185
Background. B-cell depletion with rituximab, a chimeric anti-CD20antibody, is a novel treatment for refractory and relapsingANCA-associated small-vessel vasculitis. Data are limited andmost reports describe single patients or small numbers of patientsfollowed prospectively. Methods. We report a single-centre experience with 15 patientswho received rituximab for refractory or relapsing ANCA-associatedvasculitis. All patients had been treated with corticosteroidsand cyclophosphamide and a variety of other second-line immunosuppressiveagents. None of the patients had evidence of infection and receivedfour infusions of 375 mg/m2 of rituximab. Disease activity wasassessed in accordance with the Birmingham Vasculitis ActivityScore (BVAS). BVAS, C-reactive protein and ANCA titres wererecorded at baseline and during follow-up. Results. B-cell depletion was achieved in all patients. Partialor complete remission was seen in 14 of 15 patients with a significantdecline in BVAS compared to baseline (P < 0.007). One patientwith granulomatous ANCA-associated vasculitis did not respondto rituximab. There were no side effects during rituximab infusion.Transient leucopenia was observed in two patients. One patientwith bronchial stenosis died of pneumonia 5.5 months after theinitiation of rituximab treatment. One initially anti-HBc-positive/HBsAg-negativepatient experienced a reactivation of hepatitis B, developedend-stage renal failure and died after refusal of dialysis. Conclusions. We report the largest case series of rituximabuse for ANCA-associated vasculitis so far. Our data supportthat the drug is capable of inducing partial or complete remissionin refractory or relapsing patients. Leucopenia and infectiouscomplications remain a matter of concern. 相似文献
82.
83.
J. Altirriba R. Gasa S. Casas M. J. Ramírez-Bajo S. Ros A. Gutierrez-Dalmau M. C. Ruiz de Villa A. Barbera R. Gomis 《Diabetologia》2010,53(7):1406-1414
Aims/hypothesis
Transmembrane protein 27 (TMEM27) is a membrane protein cleaved and shed by pancreatic beta cells that has been proposed as a beta cell mass biomarker. Despite reports of its possible role in insulin exocytosis and cell proliferation, its function in beta cells remains controversial. We aimed to characterise the function of TMEM27 in islets and its potential use as a beta cell mass biomarker. 相似文献84.
85.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2023,33(3):584-591
Background and aimsObesity without metabolic alterations (Metabolically Healthy Obesity, MHO) is a condition with a risk of death and cardiovascular disease lower than that of obesity associated with metabolic alterations (Metabolically Unhealthy Obesity, MUO) and similar to that of healthy non obese individuals. Inflammation is considered as a key risk factor mediating the adverse health outcomes in obesity.Methods and resultsWe compared circulating levels of thirteen major cytokines and adipokines and the expression profiles of fifteen pro-inflammatory and two anti-inflammatory genes in visceral and subcutaneous adipose tissue in a series of 16 MHO patients and in 32 MUO patients that underwent bariatric surgery. MHO was defined according to the most applied definition in current literature.Serum levels of a large set of major cytokines and adipokines did not differ between MHO and MUO patients (p ≥ 0.15). Analyses of the expression profile of pro-inflammatory and anti-inflammatory genes in subcutaneous and visceral adipose tissue failed to show differences between MHO and MUO patients (p ≥ 0.07). Sensitivity analyses applying two additional definitions of MHO confirmed the results of the primary analysis.ConclusionIn a series of metabolically healthy obese patients neither circulating levels of major cytokines and adipokines nor the gene expression profile of a large set of pro-inflammatory and anti-inflammatory genes in subcutaneous and visceral fat differed from those in metabolically unhealthy obese patients. 相似文献
86.
87.
88.
89.
90.
Abstract . Sterner G, Carlson J, Ekberg G (Malmö University Hospital, Malmö, Sweden). Raised platelet levels in diabetes mellitus complicated with nephropathy. J Intern Med 1998; 244 : 437–41.
Objectives To study if elevated platelet levels are found in early and late diabetic nephropathy.
Design A retrospective study was performed of platelet count in different subgroups of patients with insulin-dependent diabetes mellitus, including patients with long and short duration of diabetes and with early signs of nephropathy. Patients with severe renal failure subjected to renal transplantation were also included.
Results The results suggest that raised platelet levels were associated with early signs of diabetic nephropathy and with female gender. Amongst diabetics progressing to uraemia leading to renal transplant, the platelet level was 50% higher than in non-diabetic uraemic patients.
Conclusion It is concluded that raised platelet levels are a common finding in patients with diabetes mellitus complicated by nephropathy. 相似文献
Objectives To study if elevated platelet levels are found in early and late diabetic nephropathy.
Design A retrospective study was performed of platelet count in different subgroups of patients with insulin-dependent diabetes mellitus, including patients with long and short duration of diabetes and with early signs of nephropathy. Patients with severe renal failure subjected to renal transplantation were also included.
Results The results suggest that raised platelet levels were associated with early signs of diabetic nephropathy and with female gender. Amongst diabetics progressing to uraemia leading to renal transplant, the platelet level was 50% higher than in non-diabetic uraemic patients.
Conclusion It is concluded that raised platelet levels are a common finding in patients with diabetes mellitus complicated by nephropathy. 相似文献